Substituted pyrrolidines as G-protein coupled receptor 43 agonists
US11072582B2 · kind B2 · utility
0Cited by
6References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 15, 2020 |
| Grant date | Jul 27, 2021 |
| Priority date | — |
| Expiry date | Jul 15, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D413/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to novel compounds of formula (I) and their use in treating and/or preventing metabolic diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.